Nautilus Biotechnology
Nautilus is a company dedicated to revolutionizing biomedicine by unlocking the complexity of the proteome. They develop advanced single-molecule proteomics platforms that analyze billions of proteins or proteoforms at the single-molecule level, enabling broadscale and targeted proteomics studies. Their mission is to positively impact health worldwide through deep scientific innovation and transformative technology.
Industries
Nr. of Employees
medium (51-250)
Nautilus Biotechnology
San Carlos, California, United States, North America
Products
Single-molecule proteome analysis platform
Integrated platform that performs single-molecule interrogation of intact proteins on hyper-dense nanoarrays using multi-affinity probes, computational decoding, and cloud-based analysis to provide protein and proteoform identities and counts.
Single-molecule proteome analysis platform
Integrated platform that performs single-molecule interrogation of intact proteins on hyper-dense nanoarrays using multi-affinity probes, computational decoding, and cloud-based analysis to provide protein and proteoform identities and counts.
Services
Collaborative proteomics research and platform access
Engagements to collaborate on proteomics experiments and data generation using the single-molecule proteome analysis platform; includes integrated sample-to-data workflows and joint data interpretation.
Collaborative proteomics research and platform access
Engagements to collaborate on proteomics experiments and data generation using the single-molecule proteome analysis platform; includes integrated sample-to-data workflows and joint data interpretation.
Expertise Areas
- Broadscale (discovery) proteomics
- Proteoform-focused assays and analysis
- Single-molecule detection and quantification
- Affinity-reagent and probe development
Key Technologies
- Single-molecule proteomics
- Multi-affinity probe assays
- Nanofabricated hyper-dense protein arrays
- Fluorescence microscopy-based detection